Allogeneic Bone Marrow - Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease

Gastroenterology

Volumn 149, Issue 4, 2015, Pages 918-927.e6

  Molendijk, Ilse ^a   Bonsing, Bert A ^a   Roelofs, Helene ^a   Peeters, Koen C M J ^a   Wasser, Martin N J M ^a   Dijkstra, Gerard ^b   Van Der Woude, C Janneke ^c   Duijvestein, Marjolijn ^a   Veenendaal, Roeland A ^a   Zwaginga, Jaap Jan ^a   Verspaget, Hein W ^a   Fibbe, Willem E ^a   Van Der Meulen De Jong, Andrea E ^a   Hommes, Daniel W ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell Therapy; Inflammatory Bowel Disease; Perianal Fistulas; Treatment

Indexed keywords

CYTOKINE; PLACEBO;

ABDOMINAL PAIN; ADULT; ALLOTRANSPLANTATION; ANAL PUS; ANUS FISSURE; ANUS FISTULA; ARTICLE; BACKACHE; BLISTER; BONE MARROW; CARCINOMATOUS PERITONITIS; CECUM CANCER; CELL THERAPY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMEDO; COMMON COLD; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; FLATULENCE; FOLLOW UP; GASTROINTESTINAL CARCINOMA; HEADACHE; HUMAN; HUMAN TISSUE; LOSS OF APPETITE; MALE; MESENCHYMAL STROMA CELL; NAUSEA; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; OTITIS; PAIN; PERIANAL ABSCESS; PERIANAL SWELLING; PHASE 2 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SAFETY; STATISTICAL ANALYSIS; SWELLING; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VOMITING; WOUND HEALING; ADVERSE EFFECTS; BONE MARROW TRANSPLANTATION; CELL CULTURE; COMPLICATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; RECTAL FISTULA; TIME; YOUNG ADULT;

ADULT; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CROHN DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; NETHERLANDS; RECTAL FISTULA; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WOUND HEALING; YOUNG ADULT;

EID: 84942328578     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.06.014     Document Type: Article

References (30)

1. M.A. Kamm, and S.C. Ng Perianal fistulizing Crohn's disease: a call to action Clin Gastroenterol Hepatol 6 2008 7 10
2. D.A. Schwartz, E.V. Loftus Jr., W.J. Tremaine, and et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota Gastroenterology 122 2002 875 880
3. G. Hellers, O. Bergstrand, S. Ewerth, and et al. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease Gut 21 1980 525 527
4. R.L. West, C.J. van der Woude, B.E. Hansen, and et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study Aliment Pharmacol Ther 20 2004 1329 1336
5. D.C. Pearson, G.R. May, G.H. Fick, and et al. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis Ann Intern Med 123 1995 132 142
6. A.C. Ford, W.J. Sandborn, K.J. Khan, and et al. Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis Am J Gastroenterol 106 2011 644 659 quiz
7. G. Van Assche, A. Dignass, W. Reinisch, and et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: Special situations J Crohns Colitis 4 2010 63 101
8. I. Molendijk, V.J. Nuij, A.E. van der Meulen-de Jong, and et al. Disappointing durable remission rates in complex Crohn's disease fistula Inflamm Bowel Dis 20 2014 2022 2028
9. X.X. Jiang, Y. Zhang, B. Liu, and et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells Blood 105 2005 4120 4126
10. S. Beyth, Z. Borovsky, D. Mevorach, and et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Blood 105 2005 2214 2219
11. G.M. Spaggiari, H. Abdelrazik, F. Becchetti, and et al. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2 Blood 113 2009 6576 6583
12. S.M. Melief, S.B. Geutskens, W.E. Fibbe, and et al. Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6 Haematologica 98 2013 888 895
13. S.M. Melief, S.B. Geutskens, W.E. Fibbe, and et al. Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules Haematologica 98 2013 e121 e122
14. S.M. Melief, E. Schrama, M.H. Brugman, and et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages Stem Cells 31 2013 1980 1991
15. D. Garcia-Olmo, M. Garcia-Arranz, D. Herreros, and et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation Dis Colon Rectum 48 2005 1416 1423
16. D. Garcia-Olmo, D. Herreros, I. Pascual, and et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial Dis Colon Rectum 52 2009 79 86
17. F. de la Portilla, F. Alba, D. Garcia-Olmo, and et al. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial Int J Colorectal Dis 28 2013 313 323
18. R. Ciccocioppo, M.E. Bernardo, A. Sgarella, and et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease Gut 60 2011 788 798
19. Y.B. Cho, W.Y. Lee, K.J. Park, and et al. Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study Cell Transplant 22 2013 279 285
20. W.Y. Lee, K.J. Park, Y.B. Cho, and et al. Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula Stem Cells 31 2013 2575 2581
21. W.J. Sandborn, V.W. Fazio, B.G. Feagan, and et al. AGA technical review on perianal Crohn's disease Gastroenterology 125 2003 1508 1530
22. H. Hamamoto, J.H. Gorman III, L.P. Ryan, and et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage Ann Thorac Surg 87 2009 794 801
23. J.M. Hare, J.E. Fishman, G. Gerstenblith, and et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial JAMA 308 2012 2369 2379
24. M. Zaim, S. Karaman, G. Cetin, and et al. Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells Ann Hematol 91 2012 1175 1186
25. W. Wagner, S. Bork, P. Horn, and et al. Aging and replicative senescence have related effects on human stem and progenitor cells PLoS One 4 2009 e5846
26. A. Stolzing, E. Jones, D. McGonagle, and et al. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies Mech Ageing Dev 129 2008 163 173
27. H. Guadalajara, D. Herreros, P. De La Quintana, and et al. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas Int J Colorectal Dis 27 2012 595 600
28. M.M. Lalu, L. McIntyre, C. Pugliese, and et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials PLoS One 7 2012 e47559
29. M.E. Bernardo, and W.E. Fibbe Mesenchymal stromal cells: sensors and switchers of inflammation Cell Stem Cell 13 2013 392 402
30. I. Molendijk, M. Duijvestein, A.E. van der Meulen-de Jong, and et al. Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease J Allergy (Cairo) 2012 2012 187408